icatibant

FDA Drug Profile — Icatibant

Drug Details

Generic Name
icatibant
Brand Names
Icatibant
Application Number
ANDA211021
Sponsor
Hikma Pharmaceuticals USA Inc.
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
ICATIBANT ACETATE

Indications and Usage

1 INDICATIONS AND USAGE Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. Icatibant injection is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. ( 1 )